Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03230565 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Continuous Infusions vs Scheduled Bolus Infusions

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2025 to Dec 2026
    • Eligibility criteria shortened, about 12 words
    v13
  2. Secondary endpoints: 1 to 5
    • Study description expanded, about 33 words
    • Site contact updated
    v12
  3. Enrollment target: 123 to 240
    • Primary and study completion dates: Jan 16, 2024 to Dec 2025
    • Trial status: Completed to Recruiting
    • Site details revised
    v11
  4. Trial status: Enrolling by Invitation to Completed
    • Enrollment target: estimated 240 to confirmed 123
    • Primary and study completion dates changed from estimate of Dec 2023 to Jan 16, 2024
    v10
  5. Primary and study completion dates: Jul 2023 to Dec 2023v9
Show 7 earlier versionsHide 7 earlier versions
  1. Enrollment target: 62 to 240
    • Study completion date: Sep 2023 to Jul 2023
    v8
  2. Primary completion date: Jul 16, 2021 to Jul 2023
    • Study completion date: Sep 30, 2021 to Sep 2023
    v7
  3. Trial status: Recruiting to Enrolling by Invitationv6 Show 4 more changesShow less
    • Enrollment target: estimated 120 to confirmed 62
    • Primary completion date: Jun 30, 2021 to Jul 16, 2021
    • Study completion date: Jun 30, 2021 to Sep 30, 2021
    • Site details revised
  4. Primary and study completion dates: Sep 30, 2020 to Jun 30, 2021v5
  5. Primary completion date: Sep 30, 2019 to Sep 30, 2020v4
  6. Phase: Not applicable to Phase 4
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 30, 2017 to Jun 1, 2018
    • Study sites: 0 to 1
    v3
  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
Trial Details
NCT Number NCT03230565
Lead Sponsor Stanford University
Conditions
(from sponsor)		 Surgical Procedure, Unspecified, Pain, Postoperative
Related terms Postoperative Pain
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov